In previous studies, it has been shown that LPS- and ATP-induced HMGB1 release is inhibited in macrophage cultures and endotoxemia models due to genetic deletion of NLRP3 or ASC, which are the main components of the NLRP3 inflammatory model [39]. The gene discussed is HMGB1; the disease is serum lipopolysaccharide activity.